Variability in epilepsy polygenic risk prediction across Taiwanese population and clinical cohorts.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ke Yi-Syuan, Tsai Meng-Han, Ho Chen-Rui, Chou Che-Yu, Chen Hung-Hsin, Stevelink Remi, Chen Siwei, Chen Paul Chih-Hsueh, Liu Yo-Tsen, Tung Hsin, Hsiao Tzu-Hung, Tseng Sung-Hui, Chan Lung, Lee Tsong-Hai, Cheng Chih-Kuang, Jeng Jiann-Shing, Lin Chin-Hsien, Hsu Chung-Yao, Yang Yuan-Han, Yang Shun-Fa, Fan Ying-Chi, Yang Fu-Chi, Sung Yueh-Feng, Lin Shinn-Zong, Wang Tso-Fu, Liu Yuan-Hung, Chu Yu-Cheng, Chen Ming, Chang Ming-Yuh, Lee Sing-Lian, Chang Che-Cheng, Huang Yung-Chuan, Cheng Wei-Ming, Chen Shiou-Sheng, Su Yu-Hsiang, Sung Sheng-Feng, Lee Mei-Ching, Chen Jen-Tse, Feng Yen-Chen Anne
Аннотация
METHODS: Leveraging results from the latest multiancestry genome-wide association study (GWAS), we calculated PRS for all epilepsy, genetic generalized epilepsy (GGE), and focal epilepsy (FE) in two population cohorts-Taiwan Biobank-National Health Insurance Research Database (TWB-NHIRD; N ~ 105 K) and Taiwan Precision Medicine Initiative (TPMI; N ~ 500 K), with cases defined by International Classification of Diseases codes and medications-and a clinically ascertained sample (Taiwanese subset of the Epi25 consortium [Epi25-TWN]; N = 1140). PRS performance was assessed through lifetime risk models, age-at-onset stratifications, and phenome-wide association studies (PheWASs).
RESULTS: PRS performance varied substantially by cohort, epilepsy type, and age at onset. GGE PRS had the strongest effect on GGE in Epi25-TWN (per-unit odds ratio [OR] = 1.65 [95% confidence interval (CI) = 1.24-2.23], p = 8.3 × 10-4, R2 = 3.2%) but a weaker effect in TWB-NHIRD and TPMI (ORs = 1.09-1.13 [95% CI = .98-1.23], p = .002-.057, R2 = .14%-.22%). FE PRS effects on FE were more consistent but modest (ORs = 1.02-1.16 [95% CI = .97-1.33]). No prognostic value of PRS was found in predicting epilepsy from syncope or unspecified seizures. Individuals in the top 5% GGE PRS had >4-fold increased risk in Epi25-TWN but <1.5-fold in the others. Restricting to earlier onset cases strengthened PRS signals in population cohorts, particularly for GGE, with PheWAS analysis revealing epilepsy-specific associations. PRS effects were generally comparable but attenuated relative to European studies.
SIGNIFICANCE: Cohort design and phenotyping accuracy strongly influence the assessment of the predictive value of epilepsy PRS, highlighting caution in clinical interpretation. Incorporating richer phenotypic data and more diverse GWASs will be crucial to enhancing its applicability and clinical potential.